Name | Number of supported studies | Average coverage | |
---|---|---|---|
CD16-positive, CD56-dim natural killer cell, human | 5 studies | 19% ± 2% | |
natural killer cell | 4 studies | 18% ± 3% | |
epithelial cell | 4 studies | 23% ± 6% | |
glutamatergic neuron | 3 studies | 36% ± 16% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 26% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2429.58 | 180 / 180 | 100% | 21.23 | 430 / 430 |
pancreas | 100% | 1299.28 | 328 / 328 | 100% | 22.44 | 178 / 178 |
thymus | 100% | 2404.79 | 653 / 653 | 100% | 25.59 | 604 / 605 |
uterus | 100% | 2580.25 | 170 / 170 | 100% | 26.58 | 458 / 459 |
prostate | 100% | 2561.25 | 245 / 245 | 100% | 20.94 | 500 / 502 |
breast | 100% | 2167.59 | 459 / 459 | 99% | 25.54 | 1112 / 1118 |
esophagus | 100% | 2515.45 | 1445 / 1445 | 99% | 24.61 | 182 / 183 |
brain | 100% | 1795.30 | 2638 / 2642 | 100% | 20.62 | 702 / 705 |
intestine | 100% | 2824.58 | 966 / 966 | 99% | 33.13 | 523 / 527 |
skin | 100% | 2915.61 | 1809 / 1809 | 99% | 25.90 | 468 / 472 |
lung | 100% | 2571.85 | 577 / 578 | 99% | 22.37 | 1147 / 1155 |
bladder | 100% | 2582.14 | 21 / 21 | 99% | 23.99 | 499 / 504 |
kidney | 100% | 1789.82 | 89 / 89 | 99% | 16.96 | 892 / 901 |
stomach | 100% | 1801.45 | 359 / 359 | 99% | 30.43 | 283 / 286 |
adrenal gland | 100% | 1566.04 | 258 / 258 | 97% | 11.75 | 224 / 230 |
liver | 100% | 1074.63 | 226 / 226 | 88% | 10.92 | 359 / 406 |
adipose | 100% | 2133.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 24.05 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.04 | 29 / 29 |
muscle | 100% | 2074.05 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2784.24 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 21.75 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 19.94 | 1 / 1 |
blood vessel | 100% | 2320.41 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 2938.78 | 921 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1207.17 | 850 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0007605 | Biological process | sensory perception of sound |
GO_0060322 | Biological process | head development |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0001701 | Biological process | in utero embryonic development |
GO_0031122 | Biological process | cytoplasmic microtubule organization |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0034244 | Biological process | negative regulation of transcription elongation by RNA polymerase II |
GO_0090090 | Biological process | negative regulation of canonical Wnt signaling pathway |
GO_0009950 | Biological process | dorsal/ventral axis specification |
GO_0065003 | Biological process | protein-containing complex assembly |
GO_0045860 | Biological process | positive regulation of protein kinase activity |
GO_0060070 | Biological process | canonical Wnt signaling pathway |
GO_0032147 | Biological process | activation of protein kinase activity |
GO_0045732 | Biological process | positive regulation of protein catabolic process |
GO_0051248 | Biological process | negative regulation of protein metabolic process |
GO_2000060 | Biological process | positive regulation of ubiquitin-dependent protein catabolic process |
GO_0036342 | Biological process | post-anal tail morphogenesis |
GO_0048468 | Biological process | cell development |
GO_0006913 | Biological process | nucleocytoplasmic transport |
GO_0048320 | Biological process | axial mesoderm formation |
GO_0006915 | Biological process | apoptotic process |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0044725 | Biological process | epigenetic programming in the zygotic pronuclei |
GO_0005730 | Cellular component | nucleolus |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0030877 | Cellular component | beta-catenin destruction complex |
GO_0005829 | Cellular component | cytosol |
GO_0071944 | Cellular component | cell periphery |
GO_0015630 | Cellular component | microtubule cytoskeleton |
GO_0005938 | Cellular component | cell cortex |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_1990909 | Cellular component | Wnt signalosome |
GO_0005634 | Cellular component | nucleus |
GO_1990756 | Molecular function | ubiquitin-like ligase-substrate adaptor activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0070412 | Molecular function | R-SMAD binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0008013 | Molecular function | beta-catenin binding |
GO_0046332 | Molecular function | SMAD binding |
GO_0035591 | Molecular function | signaling adaptor activity |
GO_0002039 | Molecular function | p53 binding |
GO_0070411 | Molecular function | I-SMAD binding |
GO_0005515 | Molecular function | protein binding |
GO_0070016 | Molecular function | armadillo repeat domain binding |
Gene name | AXIN1 |
Protein name | Axin-1 (Axis inhibition protein 1) Axin-1 (Axis inhibition protein 1) (hAxin) Axin 1 |
Synonyms | AXIN LA16c-314G4.3-005 hCG_1984103 |
Description | FUNCTION: Component of the beta-catenin destruction complex required for regulating CTNNB1 levels through phosphorylation and ubiquitination, and modulating Wnt-signaling . Controls dorsoventral patterning via two opposing effects; down-regulates CTNNB1 to inhibit the Wnt signaling pathway and ventralize embryos, but also dorsalizes embryos by activating a Wnt-independent JNK signaling pathway . In Wnt signaling, probably facilitates the phosphorylation of CTNNB1 and APC by GSK3B . Likely to function as a tumor suppressor. Enhances TGF-beta signaling by recruiting the RNF111 E3 ubiquitin ligase and promoting the degradation of inhibitory SMAD7 . Also a component of the AXIN1-HIPK2-TP53 complex which controls cell growth, apoptosis and development . Facilitates the phosphorylation of TP53 by HIPK2 upon ultraviolet irradiation . . |
Accessions | B1AH42 A0A0S2Z4M1 ENST00000262320.8 [O15169-1] O15169 A0A0S2Z4S3 H0Y830 A0A0S2Z4R0 ENST00000457798.1 ENST00000354866.7 [O15169-2] |